| Typicality: | 0.445 |
| Saliency: | 0.244 |
| to developing countries | 4 | transitive-object |
| vaccine → be preserved with → thimerosal | 15 |
| vaccine → be produced without → thimerosal | 3 |
| negative | neutral | positive |
| 0.414 | 0.511 | 0.075 |
| Raw frequency | 18 |
| Normalized frequency | 0.244 |
| Modifier score | 0.780 |
| Perplexity | 83.060 |